CFDE Data Portal | Search RN7SL236P

	Label	Description
	RN7SL236P Gene (Entity type)	ENSG00000243870 - RNA, 7SL, cytoplasmic 236, pseudogene
	GSE126258 GSE126739 c-Myc inhibition 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE135686 etomoxir macrophage 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE112714 Ctnnb1 knockout 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE195503 progesterone 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE119369 H10 inhibition 3 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE230865 EYA2 knockdown 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Spleen 20-29 vs 70-79 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx AdiposeTissue 20-29 vs 50-59 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Pituitary 20-29 vs 70-79 Up Gene Set (Entity type)	A Gene Set from GTEx

RN7SL236P

ENSG00000243870 - RNA, 7SL, cytoplasmic 236, pseudogene

GSE126258 GSE126739 c-Myc inhibition 1 v 0 human up

A Gene Set from LINCS

GSE135686 etomoxir macrophage 2 v 3 human up

A Gene Set from LINCS

GSE112714 Ctnnb1 knockout 2 v 3 human up

A Gene Set from LINCS

GSE195503 progesterone 1 v 0 human up

A Gene Set from LINCS

GSE119369 H10 inhibition 3 v 5 human dn

A Gene Set from LINCS

GSE230865 EYA2 knockdown 1 v 0 human up

A Gene Set from LINCS

GTEx Spleen 20-29 vs 70-79 Up

A Gene Set from GTEx

GTEx AdiposeTissue 20-29 vs 50-59 Down

A Gene Set from GTEx

GTEx Pituitary 20-29 vs 70-79 Up

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.